Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01648283 · ClinicalTrials.gov registry record · NA
CYP2B6 Polymorphisms in Methadone Disposition
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01648283: Completed NA study, sponsored by Washington University School of Medicine.
NCT01648283 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01648283, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.
Primary Outcome
Plasma metabolite EDDP/methadone area under the concentration-time curve (AUC0-96) ratio
Interventions
- DRUG IV racemic methadone HCl
- DRUG Oral racemic methadone HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT01648283 record still lists
NCT01648283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which IV racemic methadone HCl is the first listed.
NCT01648283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01648283 about?
NCT01648283 is a clinical study titled "CYP2B6 Polymorphisms in Methadone Disposition". This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.
What is the current status of trial NCT01648283?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2012-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01648283?
The interventions under investigation include: IV racemic methadone HCl (DRUG), Oral racemic methadone HCl (DRUG).
Who is sponsoring clinical trial NCT01648283?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01648283's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia